NBHC Heads Into Q3 Print With Credit Losses in Focus

NBHC reports Q3 2026 results on October 28 with a single, well-defined question hanging over the print: how bad is the credit damage, and is it contained?

The options market is not braced for disaster. The put/call ratio has collapsed to 0.019, far below its 20-day average of 0.39, meaning call activity dwarfs puts by a wide margin heading into the release. Borrow conditions reinforce that picture. Availability is extraordinarily loose at 3,425%, with borrowing costs running at just 0.50%. Short interest has also been declining, down 6.4% over the past week to 4.9% of the free float, after rising roughly 21% over the prior month. The setup is one where the lending market and options positioning both point to limited bearish conviction, even as the fundamental backdrop has deteriorated.

The bull and bear cases diverge sharply on whether the damage is a one-off or a trend. Bears point to $65M of commercial loans in franchise and healthcare lending that have produced $46.8M of charge-offs, $38M to $40M of provision expense, and a $4M FinTech investment write-down. Together these items are expected to cut Q3 earnings by $0.72 to $0.76 per share against a prior Street estimate of $0.84, pushing full-year 2026 EPS to around $2.11. The concentration of problem loans and the possibility of fraud risk in the portfolio are the reasons a lingering credit overhang is hard to dismiss. Bulls counter with management's $100M buyback authorisation, up $40M from the prior programme, and a reiterated target of $1 EPS in Q4 2026, which, if achieved, would represent a sharp recovery from the Q3 hit. Analysts have maintained positive ratings throughout, with Piper Sandler holding Overweight and DA Davidson holding Buy, though both have trimmed targets through October, Piper Sandler most recently to $45 from $49 on October 15. The consensus target of $44 still implies roughly 13% upside from the current price of $38.98.

Institutional ownership adds an interesting wrinkle. BlackRock lifted its stake to 14.1% as of its July 2026 filing, up from 12% previously, making it by far the largest holder with over 6.4M shares. Dimensional Fund Advisors and State Street both crossed the 5% disclosure threshold in filings this year. On the other side, Wellington Management has trimmed from 6.5% to 4.7% and T. Rowe Price from 5.3% to 3.4%, both as of late 2025 disclosures. As always with 13D/G filings, stakes are as last disclosed around the 5% threshold and holders dropping below that level may not file again. The net read is a base that skews toward passive and index-oriented buyers rather than active stock-pickers with a strong near-term view.

NBHC's closest peers had a broadly positive week, with ASB up 3.9%, FULT up 4.0%, and GBCI gaining over 10%, suggesting the regional bank sector caught a tailwind that NBHC only partially captured, rising 2.5% on the week before slipping fractionally on Tuesday.

The print will test whether management's Q4 recovery narrative survives contact with the actual Q3 numbers, and whether the disclosed loan losses represent the full extent of the credit problem or a first instalment.